Medidata Solutions (NASDAQ: MDSO), a leading global provider of SaaS-based clinical development solutions, today announced that the Chiba University Hospital Clinical Research Center (CCRC), one of Japan's leading clinical research institutions, has chosen Medidata Rave® as its electronic data capture (EDC) and clinical data management (CDM) solution. Designated as one of the top 10 core research centers in Japan by the Ministry of Health, Labor and Welfare (MHLW), the CCRC will start using Rave this year for investigator-initiated clinical trials.
“Rave will support the CCRC in its ability to increase the number of trials it takes on each year, while also building and strengthening relationships with both pharmaceutical and academic research organizations worldwide.”
Looking to replace its existing EDC system, the CCRC chose Rave during a competitive review process of three vendors based on its ability to minimize trial costs and drive studies in any clinical research environment, across global sites and in multiple languages. Rave will also enable its team to further increase collaboration with both Japanese and major international university hospitals throughout Asia, the United States and Europe.
"We look forward to benefitting from Medidata Rave's configurable and user-friendly EDC/CDM system," said Yasuhisa Fujii, assistant professor, CCRC. "Medidata's strong reputation in Japan, particularly for its high-quality product functionality and full support services, was a key factor that influenced our decision to implement Rave."
CCRC plans to complete the Rave implementation by early 2012, leveraging Rave's built-in multi-lingual eLearning training modules to quickly bring its clinical team up to speed. CCRC also plans to participate in the Japan Medidata User Group (J-MUG), a collaborative forum where Medidata customers can share best practices.
"Medidata's established presence and leadership role in the Japanese market has allowed us to successfully serve highly regarded and innovative clinical research institutions such as the CCRC, while also supporting the clinical efforts of the global pharmaceutical industry," said Tarek Sherif, CEO, Medidata Solutions. "Rave will support the CCRC in its ability to increase the number of trials it takes on each year, while also building and strengthening relationships with both pharmaceutical and academic research organizations worldwide."
Vance wrongly blames rural hospital closures on immigrants in the country illegally